Nathalie Chauret
Bellus Health (Canada)(CA)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Inflammatory mediators and NSAID effects, Eicosanoids and Hypertension Pharmacology, HIV/AIDS drug development and treatment, Hepatitis C virus research
Most-Cited Works
- → The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K(2008)470 cited
- Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes.(1998)
- In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse.(1997)
- → Discovery of a Potent and Selective Prostaglandin D2 Receptor Antagonist, [(3R)-4-(4-Chloro- benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic Acid (MK-0524)(2007)170 cited
- → A generally applicable method for assessing the electrophilicity and reactivity of diverse nitrile-containing compounds(2006)147 cited
- → Difluoroethylamines as an amide isostere in inhibitors of cathepsin K(2010)111 cited
- → BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration(2019)99 cited